Literature DB >> 8422604

Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers.

C Mettlin1, G Jones, H Averette, S B Gusberg, G P Murphy.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8422604     DOI： 10.3322/canjclin.43.1.42

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN： 0007-9235            Impact factor:   508.702


× No keyword cloud information.
  40 in total

1.  Variation in recommendations for cancer screening among primary care physicians in New Mexico.

Authors:  C J Herman; R M Hoffman; K K Altobelli
Journal:  J Community Health       Date:  1999-08

2.  Towards a philosophy of public health.

Authors:  D L Weed
Journal:  J Epidemiol Community Health       Date:  1999-02       Impact factor: 3.710

Review 3.  Three dimensional ultrasound and prostate cancer.

Authors:  S S Mehta; A R Azzouzi; F C Hamdy
Journal:  World J Urol       Date:  2004-11-12       Impact factor: 4.226

4.  The likelihood of having a serum PSA level of ≥2.5 ng/mL according to the degree of fatty liver disease in a screened population.

Authors:  Jong Hyun Yoon; Hee Jo Yang; Jae Heon Kim; Seung Whan Doo; Won Jae Yang; Jiyoung Hwang; Seong Sook Hong; Suyeon Park; Dae Yeon Cho
Journal:  Can Urol Assoc J       Date:  2015-12-14       Impact factor: 1.862

5.  A population-based survey of prostate cancer testing in New Mexico.

Authors:  R M Hoffman; F D Gilliland
Journal:  J Community Health       Date:  1999-12

6.  Interpreting results of prostate-specific antigen testing for early detection of prostate cancer.

Authors:  J B Meigs; M J Barry; J E Oesterling; S J Jacobsen
Journal:  J Gen Intern Med       Date:  1996-09       Impact factor: 5.128

7.  Screening for prostate cancer today.

Authors:  J N Kabalin
Journal:  West J Med       Date:  1995-03

8.  Prostate cancer screening (United States).

Authors:  J W Waterbor; A J Bueschen
Journal:  Cancer Causes Control       Date:  1995-05       Impact factor: 2.506

9.  Prostate-specific antigen density--a reliable parameter for the detection of prostate cancer?

Authors:  W F Thon; F Gadban; M C Truss; M Kuczyk; U Hartmann; U Jonas
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

Review 10.  Diagnostic strategies and the incidence of prostate cancer: reasons for the low reported incidence of prostate cancer in China.

Authors:  Ling Zhang; Shan Wu; Li-Rong Guo; Xue-Jian Zhao
Journal:  Asian J Androl       Date:  2008-12-01       Impact factor: 3.285
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.